| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |